Cholestyramine Treatment Reduces Postprandial but not Fasting Serum Bile Acid Levels in Humans
|
|
- Meryl Nash
- 6 years ago
- Views:
Transcription
1 GASTROENTEROLOGY 1982;83: Cholestyramine Treatment Reduces Postprandial but not Fasting Serum Bile Acid Levels in Humans BO ANGELIN, INGEMAR BJORKHEM, KURT EINARSSON, and STAFFAN EWERTH The Departments of Medicine, Clinical Chemistry, and Surgery, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden Fasting serum concentrations of cholic acid, chenodeoxycholic acid, and deoxycholic acid were determined in healthy subjects and in patients with familial hypercholesterolemia before and during treatment with cholestyramine. The bile acids were analyzed by a specific isotope-dilution technique by using gas chromatography-mass spectrometry. Cholestyramine treatment did not change the fasting concentration of total bile acids, but the contribution of cholic acid was increased; those of chenodeoxycholic acid and deoxycholic acid were decreased. No decrease of fasting bile-acid concentrations in portal venous serum was seen in 2 cholestyramine-treated gallstone patients. The postprandial total bile-acid concentration was about 40% lower during cholestyramine treatment in healthy subjects, reflecting a reduced postprandial inflow of bile acids to the liver. This degree of interruption of the postprandial enterohepatic circulation may be sufficient to produce a n ear maximal bile-acid biosynthesis rate and to promote lowering of plasma cholesterol also in the fasting state. It is concluded that the postprandial bile-acid inflow to the liver may be more important as a regulator of bile-acid biosynthesis than is the fasting level of bile acids. Received July 29, Accepted June 4, Address requests for reprints to: Bo Angelin, M.D., Department of Medicine, Huddinge University Hospital, S Huddinge, Sweden. This study was supported by grants from the Karolinska Institutet, the Loo and Hans Osterman Foundation, and from the Swedish Medical Research Council (03X and 03X-3141). Dr. Angelin is the recipient of a fellowship from the Ernst Klenk Foundation. The authors a re grateful to Ms. Helene Saranius and Ms. Gunvor Alvelius for their expert technical assistance, and to Ms. Lena Ericsson for her skillful preparation of the manuscript by the American Gastroenterological Association /82/ $02.50 In humans, the two primary bile acids, cholic acid (CA) and chenodeoxycholic acid (CDCA), are formed in the liver from cholesterol. Together with the secondary bile acid, deoxycholic acid (DCA), they are secreted as taurine and glycine conjugates in the bile. The bile acids are partly stored in the gallbladder and released into the intestine in response to a meal. After promoting fat absorption, bile acids are efficiently reabsorbed and recirculated to the liver via the portal vein. Due to the highly efficient hepatic uptake, only small amounts of bile acids are generally detected in the peripheral circulation (1,2). Because of a constant fractional uptake over a wide range of bile acid concentrations, the peripheral venous concentration of a bile acid reflects its portal venous concentration (2). There is considerable variation in the inflow of bile acids to the liver, with three- to fivefold increases of serum bile-acid concentration in peripheral circulation after a meal (3,4). The amount of bile acids returning to the liver is assumed to regulate the conversion of cholesterol to bile acids (negative feedback) (5). Animal studies suggest that there is a diurnal variation in the biosynthesis of bile acids, with a higher synthetic activity during the feeding period (5). No information is available about humans, however, as to whether the fasting or the postprandial bile-acid inflow is the major regulator of bile-acid production rate. In the present work, we have used the experimental model of cholestyramine feeding to study how bile-acid return may regulate bile-acid synthesis. Oral administration of this bile-acid-binding resin is accompanied by an increased fecal excretion of bile acids (6,7). The increased loss of bile acids is counterbalanced by an enhanced conversion of cholesterol to bile acids in the liver (8-10), resulting in a decrease of fasting plasma cholesterol levels (11,12). We specifically tested the hypothesis that cholesty-
2 1098 ANGELIN ET AL. GASTROENTEROLOGY Vol. 83, No. 5 ramine exerts its effects on bile-acid and cholesterol metabolism by reducing the fasting inflow of bile acids to the liver. This was achieved by determining serum bile-acid levels both in the fasting state and in response to a standardized meal before and during therapy with cholestyramine. The results do not favor the concept of an important role for the fasting inflow of bile acids, but instead point to the postprandial bile-acid return as a major regulator of bileacid and cholesterol metabolism. Material and Methods Subjects and Experimental Procedures Three groups of subjects were studied under three different experimental protocols. (a) Ten patients with heterozygous familial hypercholesterolemia were studied before and during treatment with cholestyramine (Questran, Mead Johnson Pharmaceutical, Evansville, Ind.). The drug was administered at a dosage of 8 g h.ld. for 8 wk. Fasting plasma lipid and serum bile-acid levels were determined after a 12-h fast. (b) Two patients with uncomplicated cholesterol gallstones were studied during cholecystectomy after 3 wk of treatment with cholestyramine (8 g b.ld.). Portal venous blood was obtained and serum bile acids determined (ef Reference 2). (c) Eight healthy volunteers were investigated both fasting and postprandially before and during treatment with cholestyramine at a similar dose. Two blood samples were drawn from a needle inserted into an antecubital vein on the morning after a 12-h fast. The subjects were then given a standardized meal consisting of 2 dl milk, 2 cheese sandwiches, and 2 dl coffee. The energy content of this meal is 1750 kj (33% carbohydrate, 44% fat, and 23% protein). Venous blood samples were drciwn at 15-min intervals for 210 min. During the study preceded by 3 wk of treatment with cholestyramine, the subjects ingested 8 g of cholestyramine immediately preceding the meal. The ethical aspects of the present study were approved by the Ethical Committee of Karolinska Institutet on March 3, Methods Venous blood samples were allowed to clot at room temperature. Serum was obtained by centrifugation, and it was frozen at -20 C for subsequent analysis. To 0.5 ml of serum, 1 I-Lg of [2,2,3,4,4-2 Hslcholic acid, 0.5 I-Lg of [2,2,3,4,4- z Hslchenodeoxycholic acid, and 2.5 I-Lg of [11,11,12- z H 3 1deoxycholic acid were added at the same time. The serum together with the internal standards was hydrolyzed with 1 M KOH at 110 C for 12 h. The alkaline solutiqn was extracted three times with diethyl ether in order to remove most of the neutral steroids. The bile acids were then extracted from the acidified water phase with ethyl ether, methylated with diazomethane, and converted into trimethyl-silyl ether derivatives. The derivates were analyzed by gas chromatography-mass spectrometry using an LKB 9000 instrument equipped with multiple ion detector (MID) unit (LKB Instruments, Rockville, Md.). A 1.5% SE-30 column was used and the operative temperature was C. Our mass-fragmentographic technique (13) for determination of the individual bile acids, CA, CDCA, and DCA, in serum has been modified, using more specific ions for each bile-acid derivative. As a consequence, however, each bile acid must be determined separately with the instrument used here (LKB 9000). Thus, CA was analyzed with two of the channels focused on mle 623 and mle 628, corresponding to the M-15 peak in the mass spectrum of trimethyl-silyl derivative of unlabeled and [ZH1CA, respectively. Chenodeoxycholic acid was analyzed with two of the channels focused on mle 370 and 373, corresponding to the M-2 x 90 peak in the mass spectrum of trimethylshyl derivative of unlabeled and [ZH1CDCA, respectively. Deoxycholic acid was analyzed with two of the channels focused on mle 255 and 258, corresponding to the base peak in the mass spectrum of trimethyl-silyl derivative of unlabeled and [ZHIDCA, respectively. The concentrations of the individual bile acids were thus calculated from the ratios CA/[2,2, z HslCA (ratio of tracing at mle 623 to tracing at mle 628), CDCA/[2,2,3,4.4- z HslCDCA (ratio of tracing at mle 370 to tracing at mle 373), and DCAI [11,11,12- z H 3 1DCA (ratio of tracing at mle 255 to tracing at mle 258). Standard curves were used for each bile acid. As calculated from duplicate samples, the relative standard deviation of the method was 2%-3%. Plasma lipid and lipoprotein concentrations were determined as described previously (14). Data are presented as means ± standard error of the mean (SEM). Significances of differences were evaluated by Student's paired t-test (15). Results Cholestyramine treatment reduced fasting plasma total cholesterol and low-density-lipoprotein (LDL) cholesterol by about 30% in patients with familial hypercholesterolemia. Fasting serum total bile acid concentration was not changed significantly by therapy, but the concentration of CA was increased and that of DCA was reciprocally decreased (Table 1). This indicated that the portal venous inflow of bile acids was not reduced by cholestyramine treatment in the fasting state. To directly assess this, we determined the fasting concentrations of CA, CDCA, and DCA in portal venous blood from 2 cholestyramine-treated gallstone patients (Table 2). Also in this case, the relative amount of CA appeared to be increased and that of DCA reduced, whereas the total bile-acid concentration was within the normal range observed in our previously published study (2). Thus, cholestyramine treatment clearly reduced fasting total- and LDLcholesterol levels without reducing the fasting portal venous inflow of bile acids. These findings led us to formulate and test the revised hypothesis that cholestyramine exerts its
3 November 1982 CHOLESTYRAMINE TREATMENT AND SERUM BILE ACIDS 1099 Table 1. Effects of Cholestyramine Treatment G on Fasting Plasma Lipid and Serum Bile Acid Levels in Ten Patients With Heterozygous Familial Hypercholesterolemia Basal b During treatment b Cholesterol (mmolll) 9.3 ± ± 0.3" Triglycerides (mmolll) 1.6 ± ± 0.2 LDL cholesterol (mmolll) 7.0 ± ± O.4 c Cholic acid (J.LmollL) 0.37 ± ± 0.21 d Chenodeoxycholic acid (J.LmollL) 0.87 ± ± 0.14 Deoxycholic acid (J.LmollL) 0.94 ± ± 0.07 d Total bile acids(j.lmolll) 2.18 ± ± 0.34 a Dosage: 16 g daily for 8 wk. b Mean ± SEM. C Significantly different from basal period, p < d P < major effect on bile-acid enterohepatic circulation in the postprandial state. In 8 healthy subjects, cholestyramine reduced total plasma cholesterol by 20%, whereas again it did not change the fasting concentration of total bile acids (Table 3). As previously observed in hypercholesterolemic patients, the concentration of CA was increased and that of DCA decreased. With cholestyramine therapy, the postprandial increase in serum bile acids was both qualitatively and quantitatively different (Figure 1). Thus, the normal postprandial dominance of the dihydroxy bile acids, CDCA and DCA, in peripheral serum was abolished by cholestyramine treatment, and CA was the major postprandial bile acid (Table 3). After meals, the sum of CA, CDCA, and DCA was clearly reduced during cholestyramine therapy (Figure 2, Table 3). This decrease was also confirmed by calculating the mean area under the curves of total bile-acid concentrations, which showed a 40% reduction (p < 0.02). All the previous studies were performed with a dosage regimen used in clinical practice. It could be argued that the lack of effect on fasting bile-acid levels is due to the fact that only minor amounts of Table 3. Effects of Cholestyramine Treatment G on Fasting Plasma Lipid and Fasting and Postprandial Serum Bile Acid Levels in Eight Healthy Subjects Basal b During treatment b Fasting plasma lipids c Cholesterol 5.0 ± ±0.3 D Triglycerides 1.1 ± ± 0.5 Fasting serum bile acids d Cholic acid 0.24 ± ± Chenodeoxycholic acid 0.77 ± ± 0.06 Deoxycholic acid 0.82 ± ± 0.08 g Total bile acids 1.85 ± ± 0.28 Postprandial maximum d Cholic acid 0.79 ± ± 0.29 Chenodeoxycholic acid 2.78 ± ± 0.1O! Deoxycholic acid 1.54 ± ± 0.09! Total bile acids 5.69 ± ± 0.31 g Dosage: 16 g daily for 3 wk. b Mean ± SEM. C In millimoles per liter. d In micromoles per liter. e Significantly different from basal period, p < f P < g P < cholestyramine are probably present in the gut in the fasting state. The results from two additional experiments did not favor this view, however. First, when fasting serum bile acids were determined in 6 healthy subjects treated with 8 g of cholestyramine twice daily for 3 wk, the results were not different if the latter dose was given 5-6 h after the last meal of the preceding day, i.e., 7-8 h before the fasting sample was taken (2.05 ± 0.51 vs ± 0.34 /Lmoll L). Second, when hourly fasting samples were drawn after the ingestion of 8 g of cholestyramine in 6 healthy subjects (treated for 3 wk), there was no significant decrease in the total serum bile-acid concentration over a period of 5 h. Furthermore, the mean total bile-acid concentration during the 5-h fast with cholestyramine in these subjects (1.08 ± 0.19 /LmollL) was not significantly different from that seen during a similar fast without administration of the drug (1.23 ± 0.13 /LmollL). Table 2. Portal Venous Concentration of Individual Bile Acids in Two Normal Gallstone Patients Treated With Cholestyramine for Three Weeks Chenodeoxycholic Deoxycholic Total bile Cholic acid acid acid acids (J.Lmol/L) (J.LmollL) (J.LmollL) (J.LmollL) Patients Untreated patients O (Range) ( ) ( ) ( ) ( ) Data from Reference 2; n = 10.
4 1100 ANGELIN ET AL. GASTROENTEROLOGY Vol. 83, No. 5, A. B. "0 E -=-3 c:: 0 ~ c:: Q) u 5 u., "C 0.!! :c E ::l 4i III o Time Imin.! Time Iminl Figure 1. Postprandial concentrations of cholic acid (e-e), chenodeoxycholic acid (A-A), and deoxycholic acid (.-.) in 1 healthy subject during the control period (A) and during cholestyramine treatment (B). Discussion The present isotope-dilution-mass spectrometric technique, using more specific ions for each bile-acid derivative, is even more accurate than the previously used method (13). Under the conditions employed, no information was obtained with respect to the degree and nature of conjugation or sulfation of the bile acids. In this study, however, these limitations should be of minor importance. Using three different experimental protocols, we did not find any support for the hypothesis that the effects of cholestyramine on bile-acid and cholesterol metabolism are due to a reduced fasting bile-acid inflow to the liver. In all studies cholestyramine did produce qualitative changes, however, in that CA became the dominant serum bile acid. These results are in accordance with previous reports on fasting gallbladder bile composition (10,16,17), and they reflect a changed composition of the bile acid pool (8,10). It could be argued that this change in the composition of bile acids returning to the liver could be an explanation of the reduced feedback inhibition of bile-acid synthesis seen during cholestyramine treatment. However, there is presently no evidence of a difference in inhibitory capacity with regard to bile-acid production between the individual bile acids in humans (18-20). Clear changes in postprandial bile-acid inflow to the liver were brought about by cholestyramine treatment. The postprandial total bile-acid concentration was reduced by about 40%, mainly due to a reduced postprandial rise in CDCA and DCA. Cholestyramine has a greater affinity for dihydroxy than for trihydroxy bile acids in vitro (21,22). Thus, the degree of interruption of the enterohepatic circulation will be higher for CDCA and DCA than for CA. This effect will be further increased by the fact that CDCA and DCA normally are taken up more efficiently than CA in the upper intestine (23) and thus circulate faster through the enterohepatic circulation (24). The present study leads us to postulate that the powerful effects of cholestyramine treatment on cholesterol metabolism in humans are mainly the consequences of postprandial, and not fasting, interruption of bile-acid enterohepatic circulation. It is of interest to note that studies in the rhesus monkey suggest that a 20% diversion of bile flow will result in a maximum stimulation of bile-acid biosynthesis (25). Thus, the 40% reduction of the postprandial o Time Imin.! Figure 2. Means of total postprandial serum bile-acid concentrations (sum of cholic acid, chenodeoxycholic acid, and deoxycholic acid) in 8 healthy subjects during control period (_-_) and during cholestyramine treatment (e-e). Bars indicate SEM. *p < 0.05, **p < 0.01.
5 November 1982 CHOLESTYRAMINE TREATMENT AND SERUM BILE ACIDS 1101 bile-acid inflow that we recorded in the present study-using therapeutic dosages of cholestyramine-may well be sufficient to promote maximal or near-maximal stimulation of bile-acid biosynthesis during the period of the day when basal production rate is believed to be highest (5). Secondary metabolic adaptations, such as induction of hepatic lipoprotein receptors and enhanced LDL degradation (26), probably involve more slowly adjustable mechanisms and may thus persist also in the fasting state. Thus, it may be speculated that relatively transient changes in the transhepatic flux of bile acids postprandially may result in sustained effects on plasma lipoprotein metabolism. References 1. Hofmann AF. The enterohepatic circulation of bile acids in man. Adv Intern Med 1976;21: Ahlberg 1. Angelin B, Bjorkhem I, et al. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology 1977;73: LaRusso NF, Korman MG, Hoffman NE, et al. Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med 1974;291: Angelin B, Bjorkhem 1. Postprandial serum bile acids in healthy man-evidence for differences in absorptive pattern between individual bile acids. Gut 1977;18: Danielsson H, Sjovall J. Bile acid metabolism. Annu Rev Biochem 1975;33: Grundy SM, Ahrens EH, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971;78: Miettinen T. Bile acid metabolism. In: Kritchevsky 0, ed. Hypolipidemic agents. Berlin-Heidelberg-New York: Springer Verlag, 1975; Einarsson K, Hellstrom K, Kallner M. The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV. Eur J Clin Invest 1974;4: Garbutt JT, Kenney TJ. Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest 1972;51: Andersen E. The effect of cholestyramine on bile acid kinetics in healthy controls. Scand J GastroenteroI1979;14: Jones R1. Dobrilovic 1. Lipoprotein alterations with cholestyramine administration. J Lab Clin Med 1970;75: Levy RI, Fredrickson OS, Stone N1. et al. Cholestyramine in type II hyperlipoproteinemia-a double-blind trial. Ann Intern Med 1973;79: Angelin B, Bjorkhem I, Einarsson K. Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size. J Lipid Res 1978;19: Angelin B, Einarsson K, Leijd B. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid. Eur J Clin Invest 1981;11: Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press, Wood PO, Shioda R, Estrich DL, et al. Effect of cholestyramine on composition of duodenal bile in obese human subjects. Metabolism 1972;21: Angelin B, Einarsson K, Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 1979;9: Einarsson K, Hellstrom K, Kallner M. Feedback regulation of bile acid formation in man. Metabolism 1973;22: LaRusso NF, Hoffman NE, Hofmann AF, et al. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients. Gastroenterology 1975;68: Kallner M. The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV. J Lab Clin Med 1975;86: Johns WH, Bates TR. Quantification of the binding tendencies of cholestyramine. 1. Effect of structure and added electrolytes on the binding of unconjugated and conjugated bile-salt anions. J Pharm Sci 1969;58: Thale M, and Faergeman O. Binding of bile acids to anionexchanging drugs in vitro. Scand J Gastroenterol 1978; 13: Angelin B, Einarsson K, Hellstrom K. Evidence for the absorption of bile acids in the proximal small intestine of normoand hyperlipidaemic subjects. Gut 1976;17: Einarsson KA, Grundy SM, Hardison WGM. Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man. Gut 1979;20: Dowling RH, Mack E, Small OM. Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey. J Clin Invest 1970; 49: Brown MS, Kovanen PT, Goldstein JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 1981;212:
Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man
Gut, 1979, 20, 1078-1082 Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man K. A. EINARSSON,' S. M. GRUNDY, AND W. G. M. HARDISON From the Department of Meaicine, School of
More informationEffects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoprotei nemia
Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoprotei nemia Bo Angelin, Kurt Einarsson, Kjell Hellstriim, and Barbro Leijd Department of Medicine,
More informationcholesterol, and lipoprotein metabolism
116 Departnents of Surgery, J-E Akerlund L Lsijeqvist Medicine, B Angelin K Einarsson and Clinical Chemistry, Karolinska Institute at Huddinge University Hospital, Huddinge, Sweden I Bj6rkhem Correspondence
More informationEffects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia
Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia Bo Angelin' and Barbro Leijd Department of Medicine, Karolinska Institutet
More informationSerum Squalene in Patients with Gallstones*)
Hiroshima Journal of Medical Sciences Vol. 32, No. 2, June, 1983 HIJM 32-24 157 Serum Squalene in Patients with Gallstones*) Goro KAJIYAMA, Itaru HORIUCHI, Shoji NISHIMURA, Fumiaki HINO, Hiroshi SASAKI
More informationThe effect of coeliac disease upon bile salts
Gut, 1973, 14, 24-2 T. S. LOW-BEER,1 K. W. HEATON, E. W. POMARE, AND A. E. READ From the University Department of Medicine, Bristol Royal Infirmary SUMMARY The size and composition of the bile salt pool
More informationEffect of Cholestyramine on Bile Acid Metabolism in Normal Man
Effect of Cholestyramine on Bile Acid Metabolism in Normal Man J. T. GAisurr and T. J. KENNEY From the Department of Medicine, Division of Gastroenterology, Duke University Medical Center, Durham, North
More informationBile acid metabolism. doc. Ing. Zenóbia Chavková, CSc.
Bile acid metabolism doc. Ing. Zenóbia Chavková, CSc. Bile acid metabolism Importance: Availability for fat & cholesterol absorption Regulates total body pool of cholesterol Factors that synthesis promote
More informationEffect of chenodeoxycholic acid treatment in gallstone subjects
12 LI T. C. Northfield, N. F. LaRusso, A. F. Hofmann, and J. L. Thistle Effect of chenodeoxycholic acid treatment in gallstone subjects T. C. NORTHFIELD, N. F. LaRUSSO, A. F. HOFMANN, AND J. L. THISTLE
More informationMETABOLISM OF STEROID AND AMINO ACID MOIETIES OF CONJUGATED BILE ACIDS IN MAN
GASTROENTEROLOGY 72:141-148, 1977 Copyright 1977 by The Williams & Wilkins Co. Vol. 72, No.1 Printed in U.S.A. METABOLISM OF STEROID AND AMINO ACID MOIETIES OF CONJUGATED BILE ACIDS IN MAN V. Equations
More informationInterruption of the enterohepatic circulation of bile acids stimulates the esterification rate of cholesterol in human liver
Interruption of the enterohepatic circulation of bile acids stimulates the esterification rate of cholesterol in human liver Dagny StHhlberg, Eva Reihngr, Bo Angelin, and Kurt Einarsson Departments of
More informationLIVER PHYSIOLOGY AND DISEASE
GASTROENTEROLOGY 64: 298-303, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.2 Printed in U.S.A. LIVER PHYSIOLOGY AND DISEASE BILE ACID METABOLISM IN CIRRHOSIS III. Biliary lipid secretion
More informationBile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stableisotope
Gut, 1982, 23, 751-757 Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stableisotope tracer with chenodeoxycholic-11, 12-d2 acid T NISHIDA,* H MIWA, M
More informationPhysiological functions of the liver. Describe the major functions of the liver with respect to metabolism,detoxification & excretion of hydrophobic
Physiological functions of the liver. Describe the major functions of the liver with respect to metabolism,detoxification & excretion of hydrophobic substances. Describe the formation of bile,its constitents
More informationEva Reihnir, Bo Angelin, Mats Rudling, Staffan Ewerth, Ingemar Bjorkhem, and Kurt Einarsson
Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients Eva Reihnir,
More informationBILE FORMATION, ENTEROHEPATIC CIRCULATION & BILE SALTS
1 BILE FORMATION, ENTEROHEPATIC CIRCULATION & BILE SALTS Color index Important Further explanation 2 Mind map...3 Functions of bile & stages of bile secretion... 4 Characteristics & composition of bile...5
More informationEffects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects
Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects William C. Duane Department of Medicine, Veterans Affairs Medical Center and University
More informationIndividual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size
ndividual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size Bo Angelin, ngemar Bjorkhem, and Kurt Einarsson Department
More informationPharmacokinetic Model for the Metabolism and Enterohepatic Circulation of Bile Acids in Man
Description and Simulation of a Physiological Pharmacokinetic Model for the Metabolism and Enterohepatic Circulation of Bile Acids in Man CHOLIC ACID IN HEALTHY MAN A. F. HOFMANN, Division of Gastroenterology,
More informationStart Module 2: Physiology: Bile, Bilirubin. Liver and the Lab
Start Module 2: Physiology: Bile, Bilirubin Liver and the Lab Bile Physiology WYNTKFTB (Intro to Pathology) Applied Anatomy Components Function Synthesis Enterohepatic circulation Imbalance of components
More informationEffects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man
Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man Kurt Einarsson and Scott M. Grundy Department of Medicine, Veterans Administration
More informationThe effect of cholesterol feeding on bile acid. kinetics and biliary lipids in normolipidemic and hypertriglyceridemic
The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects Eva ndersen and Kjell Hellstrom Department of Medicine, St. Erik s Hospital,
More informationThe economy of the enterohepatic circulation of bile acids in the baboon. 1. Studies of controlled enterohepatic circulation of bile acids'
The economy of the enterohepatic circulation of bile acids in the baboon. 1. Studies of controlled enterohepatic circulation of bile acids' Richard N. Rediner: James W. Hawkins, and D. Michael Grace Department
More informationEffects of lovastatin and chenodiol on bile acid synthesis, bile lipid composition, and biliary lipid secretion in healthy human subjects
Effects of lovastatin and chenodiol on bile acid synthesis, bile lipid composition, and biliary lipid secretion in healthy human subjects David S. Hanson and William C. Duane' Department of Medicine, Veterans
More informationPathophysiology of Bile Secretion
Pathophysiology of Bile Secretion Martin C. Carey, D.Sc., M.D. Division of Gastroenterology, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School Boston, MA, U.S.A. Functions
More informationBiliary lipid secretion in hypercholesterolemia1
Biliary lipid secretion in hypercholesterolemia1 Tim N. Tangedahl,2 Alan F. H~fmann,~ and Bruce A. Kottke Gastroenterology Unit and Cardiovascular Research Unit, Mayo Clinic and Mayo Foundation, Rochester,
More informationLIVER PHYSIOLOGY AND DISEASE
GASTROENTEROLOGY 68: 326-334, 1975 Copyright 1975 by The Williams & Wilkins Co. Vol. 68, No.2 Printed in U.S.A. LIVER PHYSIOLOGY AND DISEASE EFFECTS OF LOW DOSE CHENODEOXYCHOLIC ACID FEEDING ON BILIARY
More informationTaurocholate is more potent than cholate in suppression of bile salt synthesis in the rat
Taurocholate is more potent than cholate in suppression of bile salt synthesis in the rat J. M. Pries, A. Gustafson, D. Wiegand, and W. C. Duane Departments of Medicine, Gastroenterology Sections, St.
More informationPATTERNS OF BILE ACIDS AND MICROFLORA IN THE HUMAN SMALL INTESTINE
G ASTROENTEROLOG Y Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.1 Printed in U.S.A. PATTERNS OF BILE ACIDS AND MICROFLORA IN THE HUMAN SMALL INTESTINE I. Bile acids ANDREW MALLORY, M.D., FRED
More informationrabbit, 45 min for dog) and more slowly for dehydrocholic acid (25- decrease, questioning the mechanism by which bile acids increase bile
J. Physiol. (1972), 224, pp. 259-269 259 With 6 text-ftgure8 Printed in Great Britain SPECIES DIFFERENCES IN THE CHOLERETIC RESPONSE TO BILE SALTS BY CURTIS D. KLAASSEN From the Clinical Pharmacology and
More informationcholesterol saturation in patients with liver cirrhosis
Gut, 1986, 27, 23-28 Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis PAOLA DI DONATO, FRANCESCA CARUBBI, M PONZ DE LEON, AND N CARULLI From Semeiotica
More informationThe enterohepatic circulation of bile acids during continuous liquid formula perfusion of the duodenum
The enterohepatic circulation of bile acids during continuous liquid formula perfusion of the duodenum P. Rutgeerts, Y. Ghoos, and G. Vantrappen Department of Medical Research, University of Leuven, University
More informationHepatic esterification rate of cholesterol and biliary lipids in human obesity
Hepatic esterification rate of cholesterol and biliary lipids in human obesity Staffan Sahlin,' Lars Granstrom, Ulf Gustafsson, Dagny Stalberg, Lars Backman, and Kurt Einarsson Department of Surgery, Danderyd
More informationAli Yaghi. Yaseen Fatayer. M.Khatatbeh
6 Ali Yaghi Yaseen Fatayer M.Khatatbeh P a g e 1 pancreatic secretions note: The pancreas has endocrine (secretions are released toward the blood) and exocrine(secretions are released through the canalicular
More informationDRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION
DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION ROUTE OF DRUG ADMINISTRATION AND EXTRAHEPATIC DRUG METABOLISM The decline in plasma concentration after drug administration
More informationCholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition
Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition William E. Connor,, Daniel B. Stone, Mark L. Armstrong J Clin Invest.
More informationEffects of Polyunsaturated Fats on Lipid Metabolism in Patients with Hypertriglyceridemia
Effects of Polyunsaturated Fats on Lipid Metabolism in Patients with Hypertriglyceridemia SCOTr M. GRUNDY From the Department of Medicine, School of Medicine, University of California, San Diego and Veterans
More informationINCREASED RATIO OF GLYCINE- TO TAURINE-CONJUGATED BILE SALTS IN PATIENTS WITH ILEAL DISORDERS
GASTROENTEROLOGY Copyright 1969 by The Williams & Wilkins Co. Vol. 56, No. 4 Printed in U.S.A. INCREASED RATIO OF GLYCINE- TO TAURINE-CONJUGATED BILE SALTS IN PATIENTS WITH ILEAL DISORDERS J. T. GARBUTT,
More informationVulnerability of keto bile acids to alkaline hydrolysis
Vulnerability of keto bile acids to alkaline hydrolysis G. Lepage, A. Fontaine, and C. C. Roy Department of Pediatrics, H6patal Ste-Justine and the University of Montreal, Montreal, Canada Summary Rigorous
More informationFecal fat, bile acid, and sterol excretion and biliary lipid changes in jejunoileostomy patients1 2
Fecal fat, acid, and sterol excretion and biliary lipid changes in jejunoileostomy patients1 2 William W. Faloon, M.D.,3 Albert Rubulis, Ph.D.,4 John Knipp, M.D.,5 Char/es D. Sherman, M.D.,6 and Mary S.
More informationANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD
ANTIHYPERLIPIDEMIA Darmawan,dr.,M.Kes,Sp.PD Plasma lipids consist mostly of lipoproteins Spherical complexes of lipids and specific proteins (apolipoproteins). The clinically important lipoproteins, listed
More informationJ. clin. Path., 26, suppl. (Ass. Clin. Path.), 5, ACTIVE TRANSPORT DIFFLS1ON. Fig 1. The normal bile acid enterohepatic circulation.
J. clin. Path., 26, suppl. (Ass. Clin. Path.), 5, 59-67 The enterohepatic circulation of bile acids as they relate to lipid disorders R. HERMON DOWLING From the MRC Intestinal Malabsorption Group, Department
More informationPLASMA DISAPPEARANCE OF RADIOACTIVITY AFTER INTRA VENOUS INJECTION OF LABELED BILE ACIDS IN MAN
GASTROENTEROLOGY 68:1567-1573, 1975 Copyright 1975 by The Williams & Wilkins Co. Vol. 68, No.6 Printed in U.S A. PLASMA DISAPPEARANCE OF RADIOACTIVITY AFTER INTRA VENOUS INJECTION OF LABELED BILE ACIDS
More informationCholesterol catabolism in the rabbit in fasted and fed states
Cholesterol catabolism in the rabbit in fasted and fed states H. C. Klauda and D. B. Zilversmit' Division of Nutritional Sciences and Section of Biochemistry, Molecular and Cell Biology, Division of Biological
More informationInternational Journal of Pharma and Bio Sciences CORRELATION OF SERUM LIPIDS AND GLUCOSE TOLERANCE TEST IN CHOLELITHIASIS
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE BIO CHEMISTRY CORRELATION OF SERUM LIPIDS AND GLUCOSE TOLERANCE TEST IN CHOLELITHIASIS Corresponding Author DEVAKI R.N Department of Biochemistry,
More informationBody Weights, and Gallbladder Disease
Bile cid Kinetics in Relation to Sex, Serum Lipids, Body Weights, and Gallbladder Disease in Patients with Various Types of Hyperlipoproteinemia KURT EINRSSON, KJELL HEusim6M, and MoR KLLNE From the Department
More informationBiliary lipid composition in idiopathic bile acid malabsorption
812 Gastroenterology Unit M Fracchia P Secreto A Pera G Galatola Central Laboratory, Ospedale Mauriziano Umberto I, Torino, Italy S Pellegrino Correspondence to: Dr G Galatola, Gastroenterology Unit, Ospedale
More informationIrritable Bowel Syndrome: Last year FODMAPs, this year bile acids
Irritable Bowel Syndrome: Last year FODMAPs, this year bile acids Lana Bistritz, MD FRCPC Division of Gastroenterology Royal Alexandra Hospital Disclosures I have no financial conflicts of interest relevant
More information4. ABSORPTION. Transport mechanisms. Absorption ABSORPTION MECHANISMS. Active transport. Active transport uses metabolic energy
4. ABSORPTION ABSORPTION MECHANISMS Once the digestive process is completed, the nutrients have to be transferred across the digestive tract epithelium into the intracellular space and eventually into
More informationMetabolism of 7P-al kyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters
Metabolism of 7P-al kyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters Mizuho Une,' Katsumi Yamanaga, Erwin H. Mosbach,' Kiyoko Tsujimura, and Takahiko Hoshita Institute
More informationpoints to the necessity in future to explore where cholesterol is stored, to what extent stored cholesterol can be
The Effects of Unsaturated Dietary Fats on Absorption, Excretion, Synthesis, and Distribution of Cholesterol in Man ScoTr M. GRUNDY and E. H. AHBENS, JR. From The Rockefeller University, New York 121 A
More informationBILIARY LIPID SECRETION BEFORE AND AFTER CHOLECYSTECTOMY IN AMERICAN INDIANS WITH CHOLESTEROL GALLSTONES
(; l\~thoe~teholor.y 6(l:1~1 ~ - 1 ~ 1-;. I ~J74 COiJ\Tight l'l,~ I,, TllP Wi ll ia m, &: Wilki ils Co. V(II. 6'3. ~(l. f) Printed ill ( r.sa. BILIARY LIPID SECRETION BEFORE AND AFTER CHOLECYSTECTOMY IN
More informationCircadian distribution of bile acid in the enterohepatic circulatory system in hamsters
Circadian distribution of bile acid in the enterohepatic circulatory system in hamsters Kang-Jey Ho Department of Pathology, Medical Center, University of Alabama in Birmingham, Birmingham, Alabama 35294
More informationNOTES: The Digestive System (Ch 14, part 2)
NOTES: The Digestive System (Ch 14, part 2) PANCREAS Structure of the pancreas: The pancreas produces PANCREATIC JUICE that is then secreted into a pancreatic duct. The PANCREATIC DUCT leads to the The
More informationObesity is an important risk factor in the development
Changes in Gallbladder Bile Composition and Crystal Detection Time in Morbidly Obese Subjects After Bariatric Surgery Ulf Gustafsson, 1 Lisbet Benthin, 2 Lars Granström, 1 Albert K. Groen, 3 Staffan Sahlin,
More informationTotal Bile Acid Assay Kit (Fluorometric)
Product Manual Total Bile Acid Assay Kit (Fluorometric) Catalog Number MET-5005 100 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Bile is a complex mixture of lipids, protein,
More informationHenry Y. I. Mok, Klaus von Bergmann, and Scott M. Grundy
Effects of continuous and intermittent feeding on biliary lipid outputs in man: application for measurements of intestinal absorption of cholesterol and bile acids Henry Y. I. Mok, Klaus von Bergmann,
More informationHydrophobic Surfactant Treatment Prevents Atherosclerosis in the Rabbit
Hydrophobic Surfactant Treatment Prevents Atherosclerosis in the Rabbit RAPID PUBLICATIONS J. B. RODGERS, E. C. KYRIAKIDES, B. KAPUSCINSKA, S. K. PENG, and W. J. BOCHENEK, Department of Medicine, Albany
More informationHepatobiliary lipids איך טיפול נולד... from bench to bedside. Fred M Konikoff, MD, MSc, FAASLD
Hepatobiliary lipids איך טיפול נולד... from bench to bedside Fred M Konikoff, MD, MSc, FAASLD Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba, and Research Laboratory of Cholesterol
More informationThe effect of cholestyramine on intestinal absorption
Gut, 1975, 16, 93-98 The effect of cholestyramine on intestinal absorption R. J. WEST AND J. K. LLOYD From the Department of Child Health, Institute of Child Health, Guildford Street, London SUMMARY Cholestyramine
More informationThe effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man
The effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man Scott M. Grundy, E. H. Ahrens Jr. J Clin Invest. 197;49(6):1135-1152. https://doi.org/1.1172/jci16329.
More informationSerum bile acids in hepatobiliary disease
Gut, 1978, 19, 492-496 Serum bile acids in hepatobiliary disease IAN A. D. BOUCHIER AND C. R. PENNINGTON From the Department of Medicine, Ninewells Hospital and Medical School, Dundee, Scotland SUMMARY
More informationAntihyperlipidemic Drugs
Antihyperlipidemic Drugs Hyperlipidemias. Hyperlipoproteinemias. Hyperlipemia. Hypercholestrolemia. Direct relationship with acute pancreatitis and atherosclerosis Structure Lipoprotein Particles Types
More informationMyBioSource.com. Total Bile Acid Assay Kit. Product Manual. Catalog Number 100 assays
Product Manual Total Bile Acid Assay Kit Catalog Number 100 assays Introduction Bile is a complex mixture of lipids, protein, carbohydrates, mineral salts, vitamins, and various trace elements, with bile
More informationAntihyperlipidemic Drugs
Antihyperlipidemic Drugs Lipid disorders: Disorders of lipid metabolism are manifest by elevation of the plasma concentrations of the various lipid and lipoprotein fractions (total and LDL cholesterol,
More informationUnit 2b: EXCRETION OF DRUGS. Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK)
Unit 2b: EXCRETION OF DRUGS By Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK) Excretion, along with metabolism and tissue redistribution,
More informationSIMULTANEOUS MEASUREMENT OF THE PANCREATIC AND BILIARY RESPONSE TO CCK AND SECRETIN
GASTROENTEROLOGY 70:403-407, 1976 Copyright 1976 by The Williams & Wilkins Co. Vol. 70, No. 3 Printed in U.S.A. SIMULTANEOUS MEASUREMENT OF THE PANCREATIC AND BILIARY RESPONSE TO CCK AND SECRETIN Primate
More informationcholesterol gall stone formation
Liver and biliary Effects of dietary sucrose on factors influencing cholesterol gall stone formation D WERNER, P M EMMETT, AND K W HEATON From the University Department of Medicine, Bristol Royal Infirmary,
More informationRole of the 26-Hydroxylase in the Biosynthesis of Bile Acids in the Normal State and in Cerebrotendinous Xanthomatosis
Role of the 26-Hydroxylase in the Biosynthesis of Bile Acids in the Normal State and in Cerebrotendinous Xanthomatosis AN IN VIVO STUDY INGEMAR BJbRKHEM, OLAV FAUSA, GUNNAR HOPEN, HELGE OFTEBRO, JAN I.
More informationTable 1 Clinical findings of diabetics. hypoglycemic agent
Table 1 Clinical findings of diabetics 1)oral hypoglycemic agent Fig. 3 The ratio of primary bile acid to total bile acid Fig. 1 Fecal wet weight Fig. 4 Fecal fatty acid Fig. 2 Fecal bile acid excretion
More informationD. N. Kim, K. T. Lee, J. M. Reiner, and W. A. Thomas MATERIALS AND METHODS. Experimental animals. Experimental design
Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine D. N. Kim, K.
More informationSkeletal muscle metabolism was studied by measuring arterio-venous concentration differences
Supplemental Data Dual stable-isotope experiment Skeletal muscle metabolism was studied by measuring arterio-venous concentration differences across the forearm, adjusted for forearm blood flow (FBF) (1).
More informationof bile acid synthesis by three different methods in hypertriglyceridemic
Measurement of bile acid synthesis by three different methods in hypertriglyceridemic and control subjects Wiuiam C. Duane Department of Medicine, GI Section (111D), Veterans Affairs Medical Center, 1
More informationCommentary. New mechanisms by which statins lower plasma cholesterol. Henri Brunengraber
Commentary New mechanisms by which statins lower plasma cholesterol Henri Brunengraber Department of Nutrition Case Western Reserve University Cleveland, OH 44109 Phone: 216 368 6429 Fax: 216 368 6560
More informationLipoprotein Formation, Structure and Metabolism: Cholesterol Balance and the Regulation of Plasma Lipid Levels
Lipoprotein Formation, Structure and Metabolism: Balance and the Regulation of Plasma Lipid Levels David E. Cohen, MD, PhD Director of Hepatology, Gastroenterology Division, Brigham and Women s Hospital
More informationFonnation of Bile Acids in Man: Conversion of Cholesterol into 53-Cholestane-3a,7a, 12a-triol in Liver Homogenates *
Fonnation of Bile Acids in Man: Conversion of Cholesterol into 53-Cholestane-3a,7a, 12a-triol in Liver Homogenates * INGEMAR BJORKHEM, HENRY DANIELSSON, KuRT EINARSSON, and GUNNAR JOHANSSON From the Department
More informationSerum bile acids in primary biliary cirrhosis
Serum bile acids in primary biliary cirrhosis G. M. MURPHY, ALISON ROSS, AND BARBARA H. BILLING From the Department of Medicine, Royal Free Hospital, London Gut, 13, 1972, 21-26 sumumary Serum bile acid
More informationImmunoassay of serum conjugates of cholic acid in
J Clin Pathol 1980; 33: 390-394 Immunoassay of serum conjugates of cholic acid in cystic fibrosis GP DAVIDSON*, MARY COREY, FREDA MORAD-HASSEL, JUDITH M SONDHEIMER, D CROZIER, AND GG FORSTNER From the
More informationSerum Lipid Profile in Pre and Post Cholecystectomy Patients
DOI: 10.7860/IJARS/2017/27123:2267 Surgery Section Original Article Serum Lipid Profile in Pre and Post Cholecystectomy Patients Kuldip Singh Ahi, Rajinder Pal Singh, Harpreet Kaur, Ashish Moudgil ABSTRACT
More informationMethods. Reference compounds (unconjugated and conjugated
Gut, 1979, 20, 698-704 Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones G. SALVIOLI' AND
More informationEffects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol
Effects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol and Fecal Steroids in Hypercholesterolemic Subjects TATU A. MIETTINEN, Second Department of Medicine, University of
More informationEffect of Oral Chenodeoxycholic Acid on Bile Acid Kinetics
Effect of Oral Chenodeoxycholic Acid on Bile Acid Kinetics and Biliary Lipid Composition in Women with Cholelithiasis RUDY C. DANZINGER, ALAN F. HOFMANN, JOHNSON L. THISTLE, and LESLIE J. SCHOENFIELD From
More informationOsnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,
Osnove farmakokinetike Aleš Mrhar Prirejeno po A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne, College of Pharmacy, University of Oklahoma Pharmacokinetics/Pharmacodynamics Pharmacodynamics
More informationEFFECT OF DEOXYCHOLIC ACID INGESTION ON BILE ACID METABOLISM AND BILIARY LIPID SECRETION IN NORMAL SUBJECTS
GASTROENTEROLOGY 72: 132-140, 1977 Copyright 1977 by The Williams & Wilkins Co. Vol. 72, No.1 Printed in U.S.A. EFFECT OF DEOXYCHOLIC ACID INGESTION ON BILE ACID METABOLISM A BILIARY LIPID SECRETION IN
More informationBile acids, the water-soluble, amphipathic end products of cholesterol metabolism, are
The Continuing Importance of Bile Acids in Liver and Intestinal Disease Alan F. Hofmann, MD REVIEW ARTICLE Bile acids, the water-soluble, amphipathic end products of cholesterol metabolism, are involved
More informationAntihyperlipidemic drugs
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein. Hyperlipidemia may caused 1. by individual
More informationANSC/NUTR 618 LIPIDS & LIPID METABOLISM The LDL Receptor, LDL Uptake, and the Free Cholesterol Pool
ANSC/NUTR 618 LIPIDS & LIPID METABOLISM The, LDL Uptake, and the Free Cholesterol Pool I. Michael Brown and Joseph Goldstein A. Studied families with familial hypercholesterolemia. B. Defined the relationship
More informationDigestion and Absorption
Digestion and Absorption Digestion and Absorption Digestion is a process essential for the conversion of food into a small and simple form. Mechanical digestion by mastication and swallowing Chemical digestion
More informationChenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis
Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis G. S. Tint,' Henry Ginsberg: Gerald Salen, Ngoc-Anh Le,t and Sarah Shefer Departments of
More informationFrom among the etiological factors for coronary artery
Cholesterol Absorption, Synthesis, and Fecal Output in Postmenopausal Women With and Without Coronary Artery Disease Radhakrishnan A. Rajaratnam, Helena Gylling, Tatu A. Miettinen Abstract Hypercholesterolemia
More informationWhat location in the gastrointestinal (GI) tract has tight, or impermeable, junctions between the epithelial cells?
CASE 32 A 17-year-old boy presents to his primary care physician with complaints of diarrhea for the last 2 days. The patient states that he just returned to the United States after visiting relatives
More informationGASTROENTEROLOGY 1983;84:253-64
GASTROENTEROLOGY 1983;84:253-64 Alteration of the Degree of Biliary Cholesterol Saturation in the Hamster and Rat by Manipulation of the Pools of Preformed and Newly Synthesized Cholesterol STEPHEN D.
More informationIleal resection: effect of cimetidine and taurine on
Gut, 1986, 27, 66-72 leal resection: effect of cimetidine and taurine on intrajejunal bile acid precipitation and lipid solubilisation W J F FTZPATRCK, P L ZENTLER-MUNRO, AND T C NORTHFELD From the Norman
More informationThe gallbladder. Bile secretion:
The gallbladder is a thin walled green muscular sac on the inferior surface of the liver. The gallbladder stores bile that is not immediately needed for digestion and concentrates it. When the muscular
More informationPLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL
PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600
More informationNMIH 206 NOTES TOPIC. Page 1 of 5
NMIH 206 NOTES TOPIC PAGE NUMBER PHARMACOKINETICS 2-15 INFECTIONS & VACCINATIONS 16-18 ANTICOAGULANT & CLOTTING TIMES 19-24 CARDIAC DRUGS: ANGININE & LANOXIN 25-27 ANAESTHETICS 28-31 NUTRITION 36-40 HYPOLIPIDAEMIC
More informationCholestatic Syndromes in Infancy: Diagnostic Value of Serum Bile Acid Pattern and Cholestyramine Administration
Pediat. Res. 7: 119-5 (1973) Bile cholestatic syndromes biliary atresia, extrahepatic cholestyramine Cholestatic Syndromes in Infancy: Diagnostic Value of Serum Bile Acid Pattern and Cholestyramine Administration
More informationMechanisms of Lithogenic Bile Formation in American Indian Women with Cholesterol Gallstones
Mechanisms of Lithogenic Bile Formation in American Indian Women with Cholesterol Gallstones ScoTT M. GRUNDY, ALLAN L. MEIZGER, and RONALD D. ADLER From the Phoenix Clinical Research Section, National
More informationInvestigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats
J. Biosci., Vol. 12, Number 2, June 1987, pp. 137 142. Printed in India. Investigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats P. VALSALA and P. A. KURUP Department
More information